Diseases of the oral cavity, including gum disorders, tooth decay and loss, and oral cancers, affect half of the human population. Specifically, incidences of oral cancers have risen by 35% over the past decade, with limited treatment modalities. Administering anti-cancer agents in close proximity to the cancerous lesion has proven clinically effective when dealing with head and neck tumors.
The present patented invention is a drug delivery system tailored for the oral cavity intended to improve the clinical management of Oral Cancers. It consists of a hybrid system, composed of bio-adhesive polymeric matrixes that harbor drug-loaded lipid nanoparticles.
- Allows for local treatment
- Reduction of tumor size prior to surgery (or replacing surgery)
Applications and Opportunities
- Local treatment for oral cancer (such as paste/cream)
Business Development Contacts
Dr. Gal Gur
Director of Business Development, Life Sciences